Physician profile
William A Garrett
NPI 1649376765
$1,283.25
in general payments reported to CMS, 2019-2025
17 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $71.72 · 2021: $88.79 · 2022: $232 · 2023: $71.07 · 2024: $82.44 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $384.85 | 2019-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $311.64 | 2023-2025 | Airsupra, Breztri |
| Abbvie INC. | $112.96 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.28 | 2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.37 | 2019-2022 | |
| Novo Nordisk INC | $57.39 | 2019-2025 | Ozempic |
| Avanos Medical | $44.32 | 2022 | |
| Amgen INC. | $38.46 | 2019 | |
| Seqirus USA INC | $33.74 | 2021-2024 | Flucelvax, Fluad |
| Genentech USA, INC. | $28.27 | 2019-2020 | |
| Pfizer INC. | $27.34 | 2022 | |
| Janssen Pharmaceuticals, INC | $24.21 | 2019-2020 | |
| Lilly USA, LLC | $22.22 | 2025 | Zepbound, Mounjaro |
| Daiichi Sankyo INC. | $22.10 | 2019 | |
| Exact Sciences Corporation | $14.82 | 2023 | Cologuard Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $14.33 | 2021 | |
| Sanofi Pasteur INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.